Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
Cardiology
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
Endocrinology
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
Gastroenterology
04
Providing nuclear medicine solutions for blood disorders and related cancers.
Hematology
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
Infectious Diseases
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
Liver & Spleen
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
Lymphology
08
Enhancing the detection and monitoring of bone and joint conditions.
Musculoskeletal
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
Nephrology
10
Advancing brain imaging solutions for neurological disorders and diseases.
Neurology
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
Oncology
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
Pulmonology
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
Radionuclide Generators
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
Rare Diseases
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
Rheumatology
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.
Urology

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Bexlutry™

(lutetium Lu 177 dotatate injection)

Active ingredient

Lutetium Lu 177 dotatate

Disease area

Oncology

Available in

Bexlutry™ in United States

Product information

Cisnaf®

CISNAF 100 MBq/mL solution for injection

Active ingredient

F18-sodium fluoride

Disease area

Oncology

Available in

Cisnaf® in France

Product information

Detectnet™

(copper Cu 64 dotatate injection)

Active ingredient

Copper Cu 64 dotatate

Disease area

Oncology

Available in

Detectnet™ in United States

Product information

Dopacis®

Fluorodopa (18F) 90 MBq/mL solution for injection

Active ingredient

F18-fluorodopa

Disease area

Neurology, Oncology

Available in
, 

Dopacis® in Belgium

Product information
, 

Dopacis® in France

Product information
, 

Dopacis® in International

Product information
, 

Dopacis® in Italy

Product information
, 

Dopacis® in Luxembourg

Product information
, 

Dopacis® in Malta

Product information
, 

Dopacis® in Netherlands

Product information
, 

Dopacis® in Portugal

Product information
, 

Dopacis® in Slovenia

Product information

Dopacis® in Spain

Product information

Erbium 169Er

Erbium (169Er) citrate 111 MBq/ml suspension for injection (ERMM-1)

Active ingredient

Er169-citrate

Disease area

Rheumatology

Available in
, 

Erbium 169Er in Czech Republic

Product information
, 

Erbium 169Er in France

Product information
, 

Erbium 169Er in Germany

Product information
, 

Erbium 169Er in International

Product information
, 

Erbium 169Er in South America

Product information

Erbium 169Er in Spain

Product information

ERtracER

ERtracER Solution for Injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

ERtracER in International

Product information
, 

ERtracER in Ireland

Product information

ERtracER in United Kingdom

Product information

Fludeomap

Fludeomap 250 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeomap in Estonia

Product information
, 

Fludeomap in Finland

Product information
, 

Fludeomap in Latvia

Product information
, 

Fludeomap in Lithuania

Product information
, 

Fludeomap in Norway

Product information

Fludeomap in Sweden

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) Monrol 200-2200 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F) in Bulgaria

Product information
, 

Fludeoxyglucose (18F) in Greece

Product information

Fludeoxyglucose (18F) in Romania

Product information

Fluorocholine (18F)

Fluorocholine (18F) CIS bio international 225 MBq/mL solution for injection

Active ingredient

F18-fluorocholine

Disease area

Oncology

Available in
, 

Fluorocholine (18F) in Belgium

Product information
, 

Fluorocholine (18F) in France

Product information
, 

Fluorocholine (18F) in International

Product information
, 

Fluorocholine (18F) in Italy

Product information
, 

Fluorocholine (18F) in Luxembourg

Product information
, 

Fluorocholine (18F) in Malta

Product information
, 

Fluorocholine (18F) in Netherlands

Product information
, 

Fluorocholine (18F) in Portugal

Product information
, 

Fluorocholine (18F) in Slovenia

Product information

Fluorocholine (18F) in Spain

Product information

GalenVita

GalenVita 0.74 –3.70 GBq radionuclide generator

Active ingredient

Germanium (68Ge) chloride / gallium (68Ga) chloride

Disease area

Radionuclide Generators

Available in
, 

GalenVita in Austria

Product information
, 

GalenVita in Belgium

Product information
, 

GalenVita in Bulgaria

Product information
, 

GalenVita in Croatia

Product information
, 

GalenVita in Cyprus

Product information
, 

GalenVita in Czech Republic

Product information
, 

GalenVita in Denmark

Product information
, 

GalenVita in Estonia

Product information
, 

GalenVita in Finland

Product information
, 

GalenVita in France

Product information
, 

GalenVita in Germany

Product information
, 

GalenVita in Greece

Product information
, 

GalenVita in Hungary

Product information
, 

GalenVita in Iceland

Product information
, 

GalenVita in Ireland

Product information
, 

GalenVita in Italy

Product information
, 

GalenVita in Latvia

Product information
, 

GalenVita in Liechestein

Product information
, 

GalenVita in Lithuania

Product information
, 

GalenVita in Luxembourg

Product information
, 

GalenVita in Malta

Product information
, 

GalenVita in Netherlands

Product information
, 

GalenVita in Norway

Product information
, 

GalenVita in Poland

Product information
, 

GalenVita in Portugal

Product information
, 

GalenVita in Romania

Product information
, 

GalenVita in Slovakia

Product information
, 

GalenVita in Slovenia

Product information
, 

GalenVita in Spain

Product information

GalenVita in Sweden

Product information

Gallium (67Ga) Citrate

Gallium Citrate Ga 67 Injection

Active ingredient

Gallium citrate Ga 67

Disease area

Infectious Diseases, Oncology, Pulmonology

Available in
, 

Gallium (67Ga) Citrate in Belgium

Product information
, 

Gallium (67Ga) Citrate in Canada

Product information
, 

Gallium (67Ga) Citrate in Costa Rica

Product information
, 

Gallium (67Ga) Citrate in Czech Republic

Product information
, 

Gallium (67Ga) Citrate in Denmark

Product information
, 

Gallium (67Ga) Citrate in France

Product information
, 

Gallium (67Ga) Citrate in Greece

Product information
, 

Gallium (67Ga) Citrate in Hungary

Product information
, 

Gallium (67Ga) Citrate in International

Product information
, 

Gallium (67Ga) Citrate in Ireland

Product information
, 

Gallium (67Ga) Citrate in Italy

Product information
, 

Gallium (67Ga) Citrate in Netherlands

Product information
, 

Gallium (67Ga) Citrate in Portugal

Product information
, 

Gallium (67Ga) Citrate in Singapore

Product information
, 

Gallium (67Ga) Citrate in Spain

Product information
, 

Gallium (67Ga) Citrate in United Kingdom

Product information

Gallium (67Ga) Citrate in United States

Product information

GlucoTep

GlucoTep 150 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in

GlucoTep in France

Product information

Indium (111In) Chloride

Indium (111In) Chloride Curiumpharma 370 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-chloride

Disease area

Infectious Diseases, Oncology

Available in
, 

Indium (111In) Chloride in Belgium

Product information
, 

Indium (111In) Chloride in Czech Republic

Product information
, 

Indium (111In) Chloride in Denmark

Product information
, 

Indium (111In) Chloride in Finland

Product information
, 

Indium (111In) Chloride in France

Product information
, 

Indium (111In) Chloride in Greece

Product information
, 

Indium (111In) Chloride in Ireland

Product information
, 

Indium (111In) Chloride in Netherlands

Product information
, 

Indium (111In) Chloride in Norway

Product information
, 

Indium (111In) Chloride in Singapore

Product information
, 

Indium (111In) Chloride in Spain

Product information
, 

Indium (111In) Chloride in Sweden

Product information
, 

Indium (111In) Chloride in Switzerland

Product information

Indium (111In) Chloride in United Kingdom

Product information

Indium (111In) DTPA

Indium (111In) DTPA 37 MBq/mL solution for injection

Active ingredient

In111-pentetate

Disease area

Neurology

Available in
, 

Indium (111In) DTPA in Belgium

Product information
, 

Indium (111In) DTPA in Czech Republic

Product information
, 

Indium (111In) DTPA in Denmark

Product information
, 

Indium (111In) DTPA in Finland

Product information
, 

Indium (111In) DTPA in France

Product information
, 

Indium (111In) DTPA in Germany

Product information
, 

Indium (111In) DTPA in Greece

Product information
, 

Indium (111In) DTPA in Ireland

Product information
, 

Indium (111In) DTPA in Italy

Product information
, 

Indium (111In) DTPA in Netherlands

Product information
, 

Indium (111In) DTPA in Spain

Product information

Indium (111In) DTPA in United Kingdom

Product information

Indium (111In) Oxinate

Indium (111In) oxinate 37 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-oxinate

Disease area

Hematology

Available in
, 

Indium (111In) Oxinate in Belgium

Product information
, 

Indium (111In) Oxinate in Czech Republic

Product information
, 

Indium (111In) Oxinate in Denmark

Product information
, 

Indium (111In) Oxinate in France

Product information
, 

Indium (111In) Oxinate in Germany

Product information
, 

Indium (111In) Oxinate in Italy

Product information
, 

Indium (111In) Oxinate in Netherlands

Product information
, 

Indium (111In) Oxinate in Spain

Product information

Indium (111In) Oxinate in Sweden

Product information

Ioflupane I 123 Injection

Ioflupane I 123 Injection

Active ingredient

Ioflupane I 123

Disease area

Neurology

Available in

Ioflupane I 123 Injection in United States

Product information

Kit for the Preparation of Technetium Tc 99m Pentetate Injection

(commonly known as DTPA)

Active ingredient

diethylenetriaminepentaacetic acid

Disease area

Nephrology, Neurology, Pulmonology

Available in

Kit for the Preparation of Technetium Tc 99m Pentetate Injection in United States

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection

Tc 99m Sestamibi Injection

Active ingredient

Cu MIBI

Disease area

Cardiology, Oncology

Available in
, 

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in Canada

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in United States

Product information

KryptoScan

KryptoScan 75-740 MBq radionuclide generator

Active ingredient

rubidium (81Rb)/krypton (81mKr)

Disease area

Pulmonology, Radionuclide Generators

Available in
, 

KryptoScan in Belgium

Product information
, 

KryptoScan in Czech Republic

Product information
, 

KryptoScan in Denmark

Product information
, 

KryptoScan in France

Product information
, 

KryptoScan in Germany

Product information
, 

KryptoScan in Ireland

Product information
, 

KryptoScan in Netherlands

Product information
, 

KryptoScan in Slovakia

Product information

KryptoScan in United Kingdom

Product information

Lutetium-177 chloride

Lutetium (¹⁷⁷Lu) chloride 40 GBq/mL radiopharmaceutical precursor

Active ingredient

Lutetium (¹⁷⁷Lu) chloride

Disease area

Oncology

Available in
, 

Lutetium-177 chloride in Austria

Product information
, 

Lutetium-177 chloride in Belgium

Product information
, 

Lutetium-177 chloride in France

Product information
, 

Lutetium-177 chloride in Germany

Product information
, 

Lutetium-177 chloride in Italy

Product information
, 

Lutetium-177 chloride in Netherlands

Product information
, 

Lutetium-177 chloride in Portugal

Product information
, 

Lutetium-177 chloride in Spain

Product information

Lutetium-177 chloride in Sweden

Product information

MIBG (I123)

MIBG (123.I) 74 MBq/mL solution for injection

Active ingredient

Iobenguane

Disease area

Oncology

Available in
, 

MIBG (I123) in Belgium

Product information
, 

MIBG (I123) in Czech Republic

Product information
, 

MIBG (I123) in Denmark

Product information
, 

MIBG (I123) in Finland

Product information
, 

MIBG (I123) in France

Product information
, 

MIBG (I123) in Germany

Product information
, 

MIBG (I123) in Hungary

Product information
, 

MIBG (I123) in Ireland

Product information
, 

MIBG (I123) in Italy

Product information
, 

MIBG (I123) in Netherlands

Product information
, 

MIBG (I123) in Norway

Product information
, 

MIBG (I123) in Slovakia

Product information
, 

MIBG (I123) in Spain

Product information
, 

MIBG (I123) in Sweden

Product information
, 

MIBG (I123) in Switzerland

Product information

MIBG (I123) in United Kingdom

Product information

Norchol-131

Norchol-131, 7,5 - 15 MBq/mL solution for injection

Active ingredient

Iodomethyl norcholesterol (131I)

Disease area

Nephrology, Oncology

Available in
, 

Norchol-131 in France

Product information
, 

Norchol-131 in International

Product information
, 

Norchol-131 in Italy

Product information

Norchol-131 in Spain

Product information

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Austria

Product information
, 

Octreoscan™ in Belgium

Product information
, 

Octreoscan™ in Canada

Product information
, 

Octreoscan™ in Czech Republic

Product information
, 

Octreoscan™ in Denmark

Product information
, 

Octreoscan™ in France

Product information
, 

Octreoscan™ in Germany

Product information
, 

Octreoscan™ in Greece

Product information
, 

Octreoscan™ in Hungary

Product information
, 

Octreoscan™ in International

Product information
, 

Octreoscan™ in Ireland

Product information
, 

Octreoscan™ in Italy

Product information
, 

Octreoscan™ in Mexico

Product information
, 

Octreoscan™ in Netherlands

Product information
, 

Octreoscan™ in Portugal

Product information
, 

Octreoscan™ in Republic of Korea

Product information
, 

Octreoscan™ in Singapore

Product information
, 

Octreoscan™ in Slovakia

Product information
, 

Octreoscan™ in Spain

Product information
, 

Octreoscan™ in Sweden

Product information
, 

Octreoscan™ in United Kingdom

Product information

Octreoscan™ in United States

Product information

Osteocis®

Osteocis, 3 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium oxidronate

Disease area

Musculoskeletal

Available in
, 

Osteocis® in International

Product information

Osteocis® in South America

Product information

ProstaTep

ProstaTep, 500 MBq/mL, solution for injection

Active ingredient

F18-fluorocholine

Disease area

Endocrinology, Oncology

Available in

ProstaTep in France

Product information

Pulmocis®

Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation

Active ingredient

macroaggregated human albumin (macrosalb)

Disease area

Pulmonology

Available in
, 

Pulmocis® in Austria

Product information
, 

Pulmocis® in Belgium

Product information
, 

Pulmocis® in Colombia

Product information
, 

Pulmocis® in Croatia

Product information
, 

Pulmocis® in Czech Republic

Product information
, 

Pulmocis® in Denmark

Product information
, 

Pulmocis® in Finland

Product information
, 

Pulmocis® in France

Product information
, 

Pulmocis® in Germany

Product information
, 

Pulmocis® in Greece

Product information
, 

Pulmocis® in International

Product information
, 

Pulmocis® in Ireland

Product information
, 

Pulmocis® in Italy

Product information
, 

Pulmocis® in Luxembourg

Product information
, 

Pulmocis® in Malta

Product information
, 

Pulmocis® in Netherlands

Product information
, 

Pulmocis® in Norway

Product information
, 

Pulmocis® in Portugal

Product information
, 

Pulmocis® in Slovakia

Product information
, 

Pulmocis® in Slovenia

Product information
, 

Pulmocis® in Spain

Product information
, 

Pulmocis® in Sweden

Product information

Pulmocis® in United Kingdom

Product information

Pulmotech™ MAA

(kit for the preparation of technetium Tc 99m albumin aggregated) injection

Active ingredient

Stannous Macroaggregated Albumin

Disease area

Pulmonology

Available in

Pulmotech™ MAA in United States

Product information

PYLCLARI®

PYLCLARI®

Active ingredient

Piflufolastat (18F)

Disease area

Oncology

Available in
, 

PYLCLARI® in Austria

Product information
, 

PYLCLARI® in Bulgaria

Product information
, 

PYLCLARI® in Croatia

Product information
, 

PYLCLARI® in Czech Republic

Product information
, 

PYLCLARI® in Denmark

Product information
, 

PYLCLARI® in Estonia

Product information
, 

PYLCLARI® in Finland

Product information
, 

PYLCLARI® in France

Product information
, 

PYLCLARI® in Germany

Product information
, 

PYLCLARI® in Greece

Product information
, 

PYLCLARI® in Hungary

Product information
, 

PYLCLARI® in Iceland

Product information
, 

PYLCLARI® in Italy

Product information
, 

PYLCLARI® in Latvia

Product information
, 

PYLCLARI® in Lithuania

Product information
, 

PYLCLARI® in Malta

Product information
, 

PYLCLARI® in Netherlands

Product information
, 

PYLCLARI® in Norway

Product information
, 

PYLCLARI® in Poland

Product information
, 

PYLCLARI® in Portugal

Product information
, 

PYLCLARI® in Romania

Product information
, 

PYLCLARI® in Slovakia

Product information
, 

PYLCLARI® in Slovenia

Product information
, 

PYLCLARI® in Spain

Product information

PYLCLARI® in Sweden

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Renocis®

kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Renocis® in Colombia

Product information
, 

Renocis® in Denmark

Product information
, 

Renocis® in Finland

Product information
, 

Renocis® in France

Product information
, 

Renocis® in Greece

Product information
, 

Renocis® in International

Product information
, 

Renocis® in Ireland

Product information
, 

Renocis® in Italy

Product information
, 

Renocis® in Peru

Product information
, 

Renocis® in Portugal

Product information
, 

Renocis® in Spain

Product information
, 

Renocis® in Sweden

Product information

Renocis® in United Kingdom

Product information

Rhenium 186Re

Rhenium (186Re) sulphide CIS bio international 148-370 MBq/mL suspension for intra-articular injection (Re-186-MM-1)

Active ingredient

Rhenium (186Re) sulphide colloid

Disease area

Rheumatology

Available in
, 

Rhenium 186Re in Czech Republic

Product information
, 

Rhenium 186Re in France

Product information
, 

Rhenium 186Re in Germany

Product information
, 

Rhenium 186Re in International

Product information
, 

Rhenium 186Re in South America

Product information

Rhenium 186Re in Spain

Product information

Seralb-125

Iodinated (125I) human albumin CIS bio international 320 kBq solution for injection

Active ingredient

I125-human albumin

Disease area

Hematology

Available in
, 

Seralb-125 in France

Product information

Seralb-125 in International

Product information

Sodium iodide (123I)

Sodium iodide (123I) CIS bio international 18.5 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology

Available in

Sodium iodide (123I) in France

Product information

Sodium iodide (¹³¹I)

MONIYOT-131 Capsule T 37-7400 MBq hard capsule for therapeutic use

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) in Denmark

Product information
, 

Sodium iodide (¹³¹I) in Germany

Product information
, 

Sodium iodide (¹³¹I) in Greece

Product information

Sodium iodide (¹³¹I) in Romania

Product information

Sodium iodide (¹³¹I) – oral solution

MONIYOT-131 14.8–3700 MBq/mL oral solution

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) – oral solution in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Denmark

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Germany

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Greece

Product information

Sodium iodide (¹³¹I) – oral solution in Romania

Product information

Sodium Iodide I-123 Capsules

Sodium Iodide I-123 Capsules

Active ingredient

Sodium Iodide I-123

Disease area

Endocrinology

Available in

Sodium Iodide I-123 Capsules in United States

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Austria

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Belgium

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Bosnia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Colombia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Costa Rica

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Czech Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Denmark

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Dominican Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Finland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in France

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Germany

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Hungary

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Italy

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Mexico

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Netherlands

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Norway

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Peru

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Portugal

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Serbia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Slovakia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Spain

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Sweden

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Switzerland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Turkey

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Sodium Iodide I123 Injection

Sodium iodide (123I) 37 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I123 Injection in Belgium

Product information
, 

Sodium Iodide I123 Injection in Czech Republic

Product information
, 

Sodium Iodide I123 Injection in Denmark

Product information
, 

Sodium Iodide I123 Injection in Finland

Product information
, 

Sodium Iodide I123 Injection in France

Product information
, 

Sodium Iodide I123 Injection in Germany

Product information
, 

Sodium Iodide I123 Injection in Hungary

Product information
, 

Sodium Iodide I123 Injection in Italy

Product information
, 

Sodium Iodide I123 Injection in Netherlands

Product information
, 

Sodium Iodide I123 Injection in Norway

Product information
, 

Sodium Iodide I123 Injection in Spain

Product information
, 

Sodium Iodide I123 Injection in Sweden

Product information
, 

Sodium Iodide I123 Injection in Switzerland

Product information

Sodium Iodide I123 Injection in United Kingdom

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Australia

Product information
, 

Stamicis® in Austria

Product information
, 

Stamicis® in Belgium

Product information
, 

Stamicis® in Colombia

Product information
, 

Stamicis® in Czech Republic

Product information
, 

Stamicis® in Denmark

Product information
, 

Stamicis® in Finland

Product information
, 

Stamicis® in France

Product information
, 

Stamicis® in Germany

Product information
, 

Stamicis® in Greece

Product information
, 

Stamicis® in India

Product information
, 

Stamicis® in International

Product information
, 

Stamicis® in Ireland

Product information
, 

Stamicis® in Israel

Product information
, 

Stamicis® in Italy

Product information
, 

Stamicis® in Luxembourg

Product information
, 

Stamicis® in Netherlands

Product information
, 

Stamicis® in Norway

Product information
, 

Stamicis® in Peru

Product information
, 

Stamicis® in Portugal

Product information
, 

Stamicis® in Republic of Korea

Product information
, 

Stamicis® in Singapore

Product information
, 

Stamicis® in Slovakia

Product information
, 

Stamicis® in Slovenia

Product information
, 

Stamicis® in Spain

Product information
, 

Stamicis® in Sweden

Product information
, 

Stamicis® in Switzerland

Product information

Stamicis® in United Kingdom

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Austria

Product information
, 

Striascan™ in Belgium

Product information
, 

Striascan™ in Bulgaria

Product information
, 

Striascan™ in Croatia

Product information
, 

Striascan™ in Cyprus

Product information
, 

Striascan™ in Czech Republic

Product information
, 

Striascan™ in Denmark

Product information
, 

Striascan™ in Estonia

Product information
, 

Striascan™ in Finland

Product information
, 

Striascan™ in France

Product information
, 

Striascan™ in Germany

Product information
, 

Striascan™ in Greece

Product information
, 

Striascan™ in Hungary

Product information
, 

Striascan™ in Iceland

Product information
, 

Striascan™ in International

Product information
, 

Striascan™ in Ireland

Product information
, 

Striascan™ in Italy

Product information
, 

Striascan™ in Latvia

Product information
, 

Striascan™ in Lithuania

Product information
, 

Striascan™ in Luxembourg

Product information
, 

Striascan™ in Malta

Product information
, 

Striascan™ in Netherlands

Product information
, 

Striascan™ in Norway

Product information
, 

Striascan™ in Poland

Product information
, 

Striascan™ in Portugal

Product information
, 

Striascan™ in Romania

Product information
, 

Striascan™ in Slovakia

Product information
, 

Striascan™ in Slovenia

Product information
, 

Striascan™ in Spain

Product information
, 

Striascan™ in Sweden

Product information
, 

Striascan™ in Switzerland

Product information
, 

Striascan™ in Turkey

Product information

Striascan™ in United Kingdom

Product information

Teceos®

Teceos 13 mg kit for radiopharmaceutical preparation

Active ingredient

Butedronate tetrasodium

Disease area

Cardiology, Oncology

Available in
, 

Teceos® in Austria

Product information
, 

Teceos® in Denmark

Product information
, 

Teceos® in Finland

Product information
, 

Teceos® in France

Product information
, 

Teceos® in Germany

Product information
, 

Teceos® in Greece

Product information
, 

Teceos® in International

Product information
, 

Teceos® in Mexico

Product information
, 

Teceos® in Netherlands

Product information
, 

Teceos® in Norway

Product information
, 

Teceos® in Republic of Korea

Product information
, 

Teceos® in Spain

Product information
, 

Teceos® in Sweden

Product information

Teceos® in Switzerland

Product information

Technescan MAG3™

(Kit for the preparation of technetium Tc99m mertiatide injection)

Active ingredient

Betiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan MAG3™ in Australia

Product information
, 

Technescan MAG3™ in Canada

Product information

Technescan MAG3™ in United States

Product information

Technescan™ DMSA

Technescan DMSA 1.2 mg kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Technescan™ DMSA in Austria

Product information
, 

Technescan™ DMSA in Belgium

Product information
, 

Technescan™ DMSA in Czech Republic

Product information
, 

Technescan™ DMSA in Denmark

Product information
, 

Technescan™ DMSA in Finland

Product information
, 

Technescan™ DMSA in France

Product information
, 

Technescan™ DMSA in Germany

Product information
, 

Technescan™ DMSA in Greece

Product information
, 

Technescan™ DMSA in Hungary

Product information
, 

Technescan™ DMSA in Ireland

Product information
, 

Technescan™ DMSA in Malaysia

Product information
, 

Technescan™ DMSA in Netherlands

Product information
, 

Technescan™ DMSA in Norway

Product information
, 

Technescan™ DMSA in Republic of Korea

Product information
, 

Technescan™ DMSA in Romania

Product information
, 

Technescan™ DMSA in Slovakia

Product information
, 

Technescan™ DMSA in Spain

Product information
, 

Technescan™ DMSA in Sweden

Product information

Technescan™ DMSA in Switzerland

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ HDP

(Kit for the Preparation of Technetium Tc 99m Oxidronate Injection)

Active ingredient

Sodium oxidronate

Disease area

Musculoskeletal

Available in
, 

Technescan™ HDP in Austria

Product information
, 

Technescan™ HDP in Belgium

Product information
, 

Technescan™ HDP in Costa Rica

Product information
, 

Technescan™ HDP in Czech Republic

Product information
, 

Technescan™ HDP in Denmark

Product information
, 

Technescan™ HDP in Dominican Republic

Product information
, 

Technescan™ HDP in Finland

Product information
, 

Technescan™ HDP in France

Product information
, 

Technescan™ HDP in Germany

Product information
, 

Technescan™ HDP in Hungary

Product information
, 

Technescan™ HDP in Ireland

Product information
, 

Technescan™ HDP in Italy

Product information
, 

Technescan™ HDP in Moldova

Product information
, 

Technescan™ HDP in Netherlands

Product information
, 

Technescan™ HDP in Norway

Product information
, 

Technescan™ HDP in Peru

Product information
, 

Technescan™ HDP in Portugal

Product information
, 

Technescan™ HDP in Republic of Korea

Product information
, 

Technescan™ HDP in Romania

Product information
, 

Technescan™ HDP in Singapore

Product information
, 

Technescan™ HDP in Slovakia

Product information
, 

Technescan™ HDP in Spain

Product information
, 

Technescan™ HDP in Sweden

Product information
, 

Technescan™ HDP in Switzerland

Product information
, 

Technescan™ HDP in Turkey

Product information

Technescan™ HDP in United Kingdom

Product information

Technescan™ HDP

(Kit for the Preparation of Technetium Tc 99m Oxidronate Injection)

Active ingredient

Sodium oxidronate

Disease area

Musculoskeletal

Available in
, 

Technescan™ HDP in Australia

Product information

Technescan™ HDP in United States

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Austria

Product information
, 

Technescan™ MAG3 in Belgium

Product information
, 

Technescan™ MAG3 in Colombia

Product information
, 

Technescan™ MAG3 in Czech Republic

Product information
, 

Technescan™ MAG3 in Denmark

Product information
, 

Technescan™ MAG3 in Finland

Product information
, 

Technescan™ MAG3 in France

Product information
, 

Technescan™ MAG3 in Germany

Product information
, 

Technescan™ MAG3 in Greece

Product information
, 

Technescan™ MAG3 in Hungary

Product information
, 

Technescan™ MAG3 in Ireland

Product information
, 

Technescan™ MAG3 in Italy

Product information
, 

Technescan™ MAG3 in Malaysia

Product information
, 

Technescan™ MAG3 in Mexico

Product information
, 

Technescan™ MAG3 in Netherlands

Product information
, 

Technescan™ MAG3 in Norway

Product information
, 

Technescan™ MAG3 in Peru

Product information
, 

Technescan™ MAG3 in Portugal

Product information
, 

Technescan™ MAG3 in Republic of Korea

Product information
, 

Technescan™ MAG3 in Slovakia

Product information
, 

Technescan™ MAG3 in Spain

Product information
, 

Technescan™ MAG3 in Sweden

Product information
, 

Technescan™ MAG3 in Switzerland

Product information
, 

Technescan™ MAG3 in Turkey

Product information

Technescan™ MAG3 in United Kingdom

Product information

Technescan™ PYP

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Technescan™ PYP in Belgium

Product information
, 

Technescan™ PYP in Colombia

Product information
, 

Technescan™ PYP in Costa Rica

Product information
, 

Technescan™ PYP in Czech Republic

Product information
, 

Technescan™ PYP in Denmark

Product information
, 

Technescan™ PYP in Finland

Product information
, 

Technescan™ PYP in France

Product information
, 

Technescan™ PYP in Germany

Product information
, 

Technescan™ PYP in Hungary

Product information
, 

Technescan™ PYP in Ireland

Product information
, 

Technescan™ PYP in Italy

Product information
, 

Technescan™ PYP in Malaysia

Product information
, 

Technescan™ PYP in Mexico

Product information
, 

Technescan™ PYP in Netherlands

Product information
, 

Technescan™ PYP in Norway

Product information
, 

Technescan™ PYP in Peru

Product information
, 

Technescan™ PYP in Republic of Korea

Product information
, 

Technescan™ PYP in Romania

Product information
, 

Technescan™ PYP in Singapore

Product information
, 

Technescan™ PYP in Spain

Product information
, 

Technescan™ PYP in Sweden

Product information
, 

Technescan™ PYP in Turkey

Product information

Technescan™ PYP in United Kingdom

Product information

Technescan™ PYP™

(kit for the preparation of technetium Tc 99m pyrophosphate injection)

Active ingredient

Tc99m-pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology, Musculoskeletal

Available in
, 

Technescan™ PYP™ in Australia

Product information

Technescan™ PYP™ in United States

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Technetium-99m generator

MONTEK 10-40 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Technetium-99m generator in Austria

Product information
, 

Technetium-99m generator in Belgium

Product information
, 

Technetium-99m generator in Bulgaria

Product information
, 

Technetium-99m generator in Denmark

Product information
, 

Technetium-99m generator in France

Product information
, 

Technetium-99m generator in Germany

Product information
, 

Technetium-99m generator in Greece

Product information
, 

Technetium-99m generator in Hungary

Product information
, 

Technetium-99m generator in Italy

Product information
, 

Technetium-99m generator in Netherlands

Product information
, 

Technetium-99m generator in Poland

Product information
, 

Technetium-99m generator in Portugal

Product information
, 

Technetium-99m generator in Romania

Product information

Technetium-99m generator in Spain

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information

Thallous Chloride Tl 201 Injection

Thallous Chloride Tl 201 Injection

Active ingredient

Tl201-Chloride

Disease area

Cardiology, Endocrinology

Available in
, 

Thallous Chloride Tl 201 Injection in Austria

Product information
, 

Thallous Chloride Tl 201 Injection in Belgium

Product information
, 

Thallous Chloride Tl 201 Injection in Czech Republic

Product information
, 

Thallous Chloride Tl 201 Injection in Denmark

Product information
, 

Thallous Chloride Tl 201 Injection in Finland

Product information
, 

Thallous Chloride Tl 201 Injection in France

Product information
, 

Thallous Chloride Tl 201 Injection in Germany

Product information
, 

Thallous Chloride Tl 201 Injection in Hungary

Product information
, 

Thallous Chloride Tl 201 Injection in Ireland

Product information
, 

Thallous Chloride Tl 201 Injection in Italy

Product information
, 

Thallous Chloride Tl 201 Injection in Netherlands

Product information
, 

Thallous Chloride Tl 201 Injection in Portugal

Product information
, 

Thallous Chloride Tl 201 Injection in Singapore

Product information
, 

Thallous Chloride Tl 201 Injection in Slovakia

Product information
, 

Thallous Chloride Tl 201 Injection in Spain

Product information
, 

Thallous Chloride Tl 201 Injection in Sweden

Product information
, 

Thallous Chloride Tl 201 Injection in Switzerland

Product information
, 

Thallous Chloride Tl 201 Injection in United Kingdom

Product information

Thallous Chloride Tl 201 Injection in United States

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Austria

Product information
, 

Ultra Technekow™ FM in Belgium

Product information
, 

Ultra Technekow™ FM in Bosnia

Product information
, 

Ultra Technekow™ FM in Colombia

Product information
, 

Ultra Technekow™ FM in Costa Rica

Product information
, 

Ultra Technekow™ FM in Cyprus

Product information
, 

Ultra Technekow™ FM in Czech Republic

Product information
, 

Ultra Technekow™ FM in Denmark

Product information
, 

Ultra Technekow™ FM in Dominican Republic

Product information
, 

Ultra Technekow™ FM in Finland

Product information
, 

Ultra Technekow™ FM in France

Product information
, 

Ultra Technekow™ FM in Germany

Product information
, 

Ultra Technekow™ FM in Greece

Product information
, 

Ultra Technekow™ FM in Hong Kong

Product information
, 

Ultra Technekow™ FM in Hungary

Product information
, 

Ultra Technekow™ FM in India

Product information
, 

Ultra Technekow™ FM in Ireland

Product information
, 

Ultra Technekow™ FM in Italy

Product information
, 

Ultra Technekow™ FM in Luxembourg

Product information
, 

Ultra Technekow™ FM in Malaysia

Product information
, 

Ultra Technekow™ FM in Moldova

Product information
, 

Ultra Technekow™ FM in Netherlands

Product information
, 

Ultra Technekow™ FM in Norway

Product information
, 

Ultra Technekow™ FM in Peru

Product information
, 

Ultra Technekow™ FM in Poland

Product information
, 

Ultra Technekow™ FM in Portugal

Product information
, 

Ultra Technekow™ FM in Republic of Korea

Product information
, 

Ultra Technekow™ FM in Romania

Product information
, 

Ultra Technekow™ FM in Serbia

Product information
, 

Ultra Technekow™ FM in Singapore

Product information
, 

Ultra Technekow™ FM in Slovakia

Product information
, 

Ultra Technekow™ FM in Spain

Product information
, 

Ultra Technekow™ FM in Sweden

Product information
, 

Ultra Technekow™ FM in Switzerland

Product information
, 

Ultra Technekow™ FM in Turkey

Product information

Ultra Technekow™ FM in United Kingdom

Product information

Ultra-Technekow™ V4

(technetium Tc 99m generator)

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators, Urology

Available in
, 

Ultra-Technekow™ V4 in Canada

Product information

Ultra-Technekow™ V4 in United States

Product information

Ultratag™ RBC

(Kit for the Preparation of Technetium Tc 99m Red Blood Cells Injection)

Active ingredient

N/A

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Ultratag™ RBC in Czech Republic

Product information
, 

Ultratag™ RBC in Denmark

Product information
, 

Ultratag™ RBC in Hungary

Product information
, 

Ultratag™ RBC in Netherlands

Product information

Ultratag™ RBC in Slovakia

Product information

Ultratag™ RBC

(Kit for the Preparation of Technetium Tc 99m Red Blood Cells Injection)

Active ingredient

N/A

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Ultratag™ RBC in Australia

Product information
, 

Ultratag™ RBC in Canada

Product information

Ultratag™ RBC in United States

Product information

Vasculocis®

Vasculocis 10 mg kit for radiopharmaceutical preparation

Active ingredient

human serum albumin

Disease area

Cardiology

Available in
, 

Vasculocis® in Belgium

Product information
, 

Vasculocis® in Denmark

Product information
, 

Vasculocis® in Finland

Product information
, 

Vasculocis® in France

Product information
, 

Vasculocis® in International

Product information
, 

Vasculocis® in Luxembourg

Product information
, 

Vasculocis® in Netherlands

Product information

Vasculocis® in Sweden

Product information

Xenon Xe 133 Gas

Xenon Xe 133 Gas

Active ingredient

Xenon Xe-133

Disease area

Neurology, Pulmonology

Available in

Xenon Xe 133 Gas in United States

Product information

Xenotron™ I Dispenser

Xenon (Xe 133) Gas Dispenser

Active ingredient

N/A device

Disease area

Neurology, Pulmonology

Available in

Xenotron™ I Dispenser in United States

Product information

Yttrium 90Y

Yttrium (90Y) citrate CIS bio international 150-370 MBq/mL suspension for intraarticular injection (YMM-1)

Active ingredient

Y90-citrate

Disease area

Rheumatology

Available in
, 

Yttrium 90Y in Belgium

Product information
, 

Yttrium 90Y in Czech Republic

Product information
, 

Yttrium 90Y in France

Product information
, 

Yttrium 90Y in Germany

Product information
, 

Yttrium 90Y in Hungary

Product information
, 

Yttrium 90Y in International

Product information
, 

Yttrium 90Y in Italy

Product information
, 

Yttrium 90Y in Luxembourg

Product information
, 

Yttrium 90Y in Netherlands

Product information
, 

Yttrium 90Y in Slovakia

Product information
, 

Yttrium 90Y in South America

Product information
, 

Yttrium 90Y in Spain

Product information

Yttrium 90Y in Switzerland

Product information
Next page
R&D Innovators